Showing results (501-510 of 585) with videos related to
Sort By:
Pageof 59
Human Gene Therapy|March 12, 2005
Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii proteinYu Wang, Minzhen Xu, Mingxin Che, et al.British Journal of Cancer|February 9, 2013
Management of colorectal cancer explains differences in 1-year relative survival between France and England for patients diagnosed 1997-2004O Dejardin, B Rachet, E Morris, et al.British Journal of Haematology|June 26, 2003
Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantationRaymond Wong, Guillermo Z Beguelin, Marcos de Lima, et al.Nutrition and Cancer|October 7, 2010
Soy isoflavones in conjunction with radiation therapy in patients with prostate cancerIftekhar U Ahmad, Jeffrey D Forman, Fazlul H Sarkar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809R I Fisher, B W Dana, M LeBlanc, et al.The Journal of Physical Chemistry. B|August 18, 2023
Delineating Structural Propensities of the 4E-BP2 Protein via Integrative Modeling and ClusteringThomas E Tsangaris, Spencer Smyth, Gregory-Neal W Gomes, et al.Biorxiv : the Preprint Server for Biology|July 17, 2026
Competing effects modulate the rate of poly(A) RNA deadenylation in a biomolecular condensateRose M Irwin, Robert W Harkness, Brian Tsang, et al.Nutrition and Cancer|October 12, 2007
Lycopene and soy isoflavones in the treatment of prostate cancerUlka Vaishampayan, Maha Hussain, Mousumi Banerjee, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 13, 2016
Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancerJeffrey V Brower, Jeffrey D Forman, Patrick A Kupelian, et al.Nucleic Acids Research|March 30, 2012
Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 bindingCecilia Andresen, Sara Helander, Alexander Lemak, et al.Pageof 59